Published in Medical Letter on the CDC and FDA, November 6th, 2005
All customers who have received shipments of Menactra vaccine are being contacted and informed of these reports and reminded of the importance of reporting vaccine adverse events.
Sanofi pasteur supports an immediate and thorough investigation of all aspects of these reported cases and is working closely with the U.S. Food and Drug Administration (FDA) and the U.S. Centers for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.